Goldman Sachs has invested INR11.2 billion ($150 million) in Biocon Biologics, the biosimilars business of Indian pharmaceuticals manufacturer Biocon, at a post-money valuation of $3.94 billion.
The investment takes the form of optionally convertible debentures. It follows a commitment of INR2.25 billion from Tata Capital Growth Fund in August and INR5.36 billion from True North in January. The...
Zhuanzhuan, a used goods trading platform and subsidiary of 58.com, China’s largest online classifieds marketplace, has raised a $100 million round led by electronics giant Xiaomi.
KPCB growth-stage spinout Bond has led a $200 million Series B round for BrowserStack, a software testing platform established by two Indian entrepreneurs.
Chinese healthcare big data company LinkDoc Technology, which counts New Enterprise Associates (NEA), China Broadband Capital, and Temasek Holdings among its investors, has filed for an IPO in the US.
Yonghe Medical Group, a Chinese hair healthcare specialist best known for hair transplants, is targeting a Hong Kong IPO. Its largest external shareholder is CPE, formerly CITIC Private Equity.